Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma - Concepedia

Concepedia

Publication | Open Access

Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma

DOI Full Paper Access

42

Citations

27

References

2013

Year

Tim Illidge, Clara C. Chan, Nicholas Counsell, Stephen Morris, Julia Scarisbrick, D. Gilson, Bilyana Popova, Pip Patrick, Peter Smith, Sean Whittaker,

British Journal of Cancer

Abstract

The overall response rate of the combination did not reach the specified target to proceed further and is lower than that previously reported for gemcitabine as a single agent.

References

	Year	Citations

Page 1